Formulate the future: Securing sustainable supply of critical ingredients for vaccines
We envision a future where everyone gets the vaccines they need. This reality relies on maintaining vaccine access and continuing to innovate in this realm. The responsibility is on us all to not only select sustainable ingredients, but to secure supply chains and sources that will not deplete in the future.
Future-ready vaccines start with sustainable supply
Tomorrow’s vaccines depend on resilient, scalable supply chains that support both global health and the natural world. Building that future means choosing critical ingredients that deliver performance without compromising biodiversity.
Squalene is a proven ingredient in vaccine adjuvant systems used in seasonal and pandemic vaccines. Traditionally sourced from shark liver, it presents a clear biodiversity challenge and highlights the need for a more sustainable alternative.
That challenge sits within a wider global agenda. IPBES (Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services), the leading global platform on biodiversity, translates science into action and helps policymakers and organisations understand why nature matters - and what to do to protect it. It works alongside the IPCC (Intergovernmental Panel on Climate Change) to show that climate change and nature loss are deeply connected - and that effective solutions must address both together.
Partnering for Sustainably Sourced Squalene
The strategic partnership with Amyris Inc., a leader in synthetic biology, helped accelerating the commercial availability of Sustainably Sourced Squalene that fulfils the stringent requirements from vaccine manufacturers while supporting supply security and reducing pressure on marine biodiversity.
It is not only an example of how Croda implements our Commitment, to be Climate, Land, People, and Nature Positive by 2030. It further demonstrates how innovation, better data and collaboration can contribute to nature-positive transformation in line with IPBES’ advice.
Contact us to continue your sustainable journey today!
Whitepaper: Vaccines for a more sustainable future
Exceptional standards in adjuvant manufacturing
A history of supporting vaccines
Dedicated to your vaccine success
Register your interest:
Supporting Literature
Empowering the development of tomorrow's vaccines
